Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 4/20 | 0.52 |
| ▸ | ERAP2 | Q6P179 | 4/20 | 0.49 |
| ▸ | IL1RN | P18510 | 3/20 | 0.49 |
| ▸ | ERAP1 | Q9NZ08 | 3/20 | 0.49 |
| ▸ | REN | P00797 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | CTSL | P07711 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.48 |
| ▸ | CTSK | P43235 | 1/20 | 0.48 |
| ▸ | TACR1 | P25103 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24301402 | 0.92 | MAPT (0.49) | CCKBRRENTP53MAPTCTSL | |
| SCHEMBL24301268 | 0.92 | IL1RN (0.55) | ERAP2IL1RNERAP1TACR1 | |
| SCHEMBL24301412 | 0.91 | MAGI3 (0.49) | CCKBRRENTP53MAPTCTSL | |
| SCHEMBL24301522 | 0.91 | ACE (0.52) | CCKBRRENTP53MAPTCTSL | |
| SCHEMBL24301420 | 0.91 | ERAP2 (0.51) | ERAP2IL1RNERAP1TACR1 | |
| SCHEMBL24301243 | 0.91 | TACR1 (0.53) | ERAP2IL1RNERAP1TP53MAPT | |
| SCHEMBL24301257 | 0.89 | ERAP2 (0.63) | ERAP2IL1RNERAP1RENTP53 | |
| SCHEMBL24301424 | 0.89 | MAGI3 (0.53) | CCKBRRENTP53MAPTCTSL | |
| SCHEMBL24301283 | 0.88 | ERAP2 (0.49) | ERAP2IL1RNERAP1MAPTTACR1 | |
| SCHEMBL24301735 | 0.87 | CTSL (0.53) | CCKBRRENTP53MAPTCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022078462-A1 | NOVEL GLUTAMINE ANALOGS | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2022-04-21 | — | — | WO | disclosed |